Sort
82,697 grants matching “vaccine development”
Control Systems Governing Short vs Longterm Humoral & Cellular Immunity
$834,563Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2015 · AI
Novel epitopes that mediate broad neutralization of clade B and C HIV-1 isolates
$834,555Abraham Pinter · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2009 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$834,536Angela Diaz · Icahn School Of Medicine At Mount Sinai · R56 · FY2012 · AI
Optimization of Lead BKIs for Cryptosporidiosis Therapy
$834,465Wesley C Van Voorhis · University Of Washington · R01 · FY2021 · AI
Natural History of Pre-diabetic Autoimmunity (DAISY)
$834,397Marian J. Rewers · University Of Colorado Denver · R37 · FY2009 · DK
Mechanisms and means to improve HIV bnAb activity in vivo
$834,325Margaret E Ackerman · Dartmouth College · R01 · FY2025 · AI
Mechanisms of Antibody-Mediated Neutralization of Flavirus Infection
$834,290Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Development of a novel highly effective influenza vaccine
$834,285Pamuk Bilsel · Flugen, Inc. · R44 · FY2018 · AI
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
$834,248Bing Chen · Boston Children'S Hospital · R01 · FY2021 · AI
BIOMEDICAL RESEARCH INFRASTRUCTURE AT ALABAMA STATE UNI*
$834,195Kennedy S Wekesa · Alabama State University · P20 · FY2006 · MD
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
$834,191Kevin O Saunders · Duke University · U19 · FY2023 · AI
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
$834,107Bing Chen · Boston Children'S Hospital · R01 · FY2017 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$834,105Chetan Seshadri · University Of Washington · R01 · FY2020 · AI
Non-Human Primate Core
$833,993Ivona Pandrea · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · AI
Influenza pathogenesis in pregnancy
$833,919Kristina M Adams Waldorf · University Of Washington · R01 · FY2025 · AI
Development of mRNA-platform vaccines
$833,885Fredrick Heath Damron · West Virginia University · R01 · FY2022 · AI
Diet and Duration of Cervical HPV Infection
$833,781Marc T Goodman · University Of Hawaii At Manoa · R01 · FY2006 · CA
Optimizing Adjuvants and Needle Free Delivery Methods for Oral HIV Vaccination
$833,778Rama Rao Amara · Emory University · R01 · FY2017 · DE
Development of an Adenovirus based HCV Vaccine: preclinical safety and immunology
$833,701Alfredo Nicosia · Okairos · U01 · FY2007 · AI
Environmental Causes of Type 1 Diabetes
$833,610Marian J. Rewers · University Of Colorado Denver · U01 · FY2007 · DK
TISSUE BIOSPECIMEN AND PATHOLOGY RESOURCE
$833,601Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P30 · FY2017 · CA
TISSUE BIOSPECIMEN AND PATHOLOGY RESOURCE
$833,601Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P30 · FY2016 · CA
TISSUE BIOSPECIMEN AND PATHOLOGY RESOURCE
$833,601Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P30 · FY2015 · CA
Evaluation of modified versus unmodified mRNAs in lipid nanoparticles to generate Anti-HIV CD8 T cell responses in rhesus macaques
$833,577Francois Villinger · University Of Louisiana At Lafayette · N01 · FY2022 · AI
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness
$833,534Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R56 · FY2023 · AI